AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12095381 — intervention group
Group type: EXPERIMENTAL
Intervention: Indinavir
Number of subjects: 481
Study 12095381 — intervention group
Group type: EXPERIMENTAL
Intervention: Nelfinavir
Number of subjects: 481
Study 12095381 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 481
Study 12095381 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined dual-PI arms
Number of subjects: 481
Study 12095381 — intervention group
Group type: EXPERIMENTAL
Intervention: NNRTI-naive patients
Number of subjects: 481
Study 12095381 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline HIV-1 hypersusceptibility to efavirenz
Number of subjects: 481
Study 12095381 — intervention group
Group type: EXPERIMENTAL
Intervention: More than 10-fold reduction in efavirenz susceptibility
Number of subjects: 481
Study 10512915 — intervention group
Group type: EXPERIMENTAL
Intervention: Task-oriented treadmill exercise (3 times/week for 12 weeks)
Number of subjects: 14
Study 7671566 — intervention group
Group type: EXPERIMENTAL
Intervention: High sodium intake (260 mmol/day) with arginine vasopressin infusion (2 fmol min‐1 kg‐1)
Number of subjects: 0
Study 7671566 — intervention group
Group type: EXPERIMENTAL
Intervention: Low sodium intake (20 mmol/day) with arginine vasopressin infusion (2 fmol min‐1 kg‐1)
Number of subjects: 0
Study 2111414 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunochemotherapy with PSK and/or OK-432
Number of subjects: 266
Study 2111414 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 266
Study 2111414 — intervention group
Group type: EXPERIMENTAL
Intervention: Administration of PSK
Number of subjects: 266
Study 2111414 — intervention group
Group type: EXPERIMENTAL
Intervention: High SI group
Number of subjects: 266
Study 2111414 — intervention group
Group type: EXPERIMENTAL
Intervention: Low SI group
Number of subjects: 266
Study 7244752 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous epinephrine (various doses)
Number of subjects: 77
Study 7244752 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal epinephrine therapy
Number of subjects: 77
Study 31415003 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastric reconstruction with duodenal diversion plus Roux-en-Y anastomosis (RY)
Number of subjects: 60
Study 31415003 — intervention group
Group type: COMPARATOR
Intervention: Standard gastric reconstruction (non-RY)
Number of subjects: 60
Study 30552589 — intervention group
Group type: EXPERIMENTAL
Intervention: Articaine group - inferior alveolar nerve block with lignocaine (2%) adrenaline (1:80000) + Buccal infiltration with articaine (4%) with adrenaline (1:100000)
Number of subjects: 60
Study 30552589 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold group - inferior alveolar nerve block with lignocaine (2%) adrenaline (1:80000) + cold application
Number of subjects: 60
Study 30552589 — intervention group
Group type: COMPARATOR
Intervention: Control group - inferior alveolar nerve block with lignocaine (2%) adrenaline (1:80000)
Number of subjects: 60
Study 29425385 — intervention group
Group type: EXPERIMENTAL
Intervention: Accommodative IOL (Lumina; AkkoLens Clinical BV)
Number of subjects: 63
Study 27538109 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone gel sheeting applied to one foot scar for 12 weeks
Number of subjects: 2
Study 27538109 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated scar)
Number of subjects: 2
Study 24552282 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 180
Study 24552282 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (FLX)
Number of subjects: 180
Study 24552282 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study 22908837 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen (HBO2) therapy at 2.4 atm abs for 40 sessions over 8 to 11 weeks
Number of subjects: 242
Study 22908837 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment at 1.2 atm abs for 40 sessions over 8 to 11 weeks
Number of subjects: 242
Study 22908837 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving room air for 40 sessions over 8 to 11 weeks
Number of subjects: 242
Study 20513728 — intervention group
Group type: EXPERIMENTAL
Intervention: bivalirudin
Number of subjects: 17073
Study 20513728 — intervention group
Group type: COMPARATOR
Intervention: heparin
Number of subjects: 17073
Study 20513728 — intervention group
Group type: EXPERIMENTAL
Intervention: aVR ST elevation > or =1 mm
Number of subjects: 17073
Study 20513728 — intervention group
Group type: EXPERIMENTAL
Intervention: aVR ST elevation > or =1.5 mm for anterior AMI
Number of subjects: 17073
Study 20513728 — intervention group
Group type: EXPERIMENTAL
Intervention: aVR ST elevation > or =1 mm for inferior AMI
Number of subjects: 17073
Study 20513728 — intervention group
Group type: EXPERIMENTAL
Intervention: resolution of ST elevation in aVR to <1 mm after fibrinolytic therapy
Number of subjects: 17073
Study 20513728 — intervention group
Group type: EXPERIMENTAL
Intervention: new ST elevation > or =1 mm after fibrinolytic therapy
Number of subjects: 17073
Study 17047016 — intervention group
Group type: EXPERIMENTAL
Intervention: GH treatment
Number of subjects: 52
Study 17047016 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 52
Study 16393215 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg once daily
Number of subjects: 406
Study 16393215 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 20 mg once daily
Number of subjects: 406
Study 16393215 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine 150 mg twice daily
Number of subjects: 406
Study 11004863 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitogenic stimulation of peripheral blood lymphocytes by PHA (1 microgram/ml)
Number of subjects: 57
Study 11004863 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolic activity of neutrophils measured by chemiluminescence (CL)
Number of subjects: 57
Study 11004863 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunoglobulins (IgG, IgA, IgM) concentration in serum (radial immunodiffusion)
Number of subjects: 57
Study 11004863 — intervention group
Group type: EXPERIMENTAL
Intervention: TNF‐alpha concentration in serum (ELISA)
Number of subjects: 57
Study 11004863 — intervention group
Group type: EXPERIMENTAL
Intervention: E‐rosette tests (with theophylline)
Number of subjects: 57
Study 9486935 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE gene I/D polymorphism
Number of subjects: 80
Study 9486935 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive drug treatment
Number of subjects: 80
Study 9486935 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight gain between hemodialysis
Number of subjects: 80
Study 9486935 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean blood pressure after hemodialysis
Number of subjects: 80
Study 9486935 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum creatinine
Number of subjects: 80
Study 9486935 — intervention group
Group type: EXPERIMENTAL
Intervention: Male gender
Number of subjects: 80
Study 8275165 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 3013800 — intervention group
Group type: EXPERIMENTAL
Intervention: High doses of prednisone
Number of subjects: 0
Study 3013800 — intervention group
Group type: COMPARATOR
Intervention: ACTH
Number of subjects: 0
Study 3013800 — intervention group
Group type: COMPARATOR
Intervention: Cyclophosphamide
Number of subjects: 0
Study 30741863 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined resistance training (CRT) program
Number of subjects: 12
Study 30741863 — intervention group
Group type: COMPARATOR
Intervention: Traditional cricket training (TCT) program
Number of subjects: 12
Study 30741863 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 12
Study 31851436 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramelteon and/or Suvorexant
Number of subjects: 948
Study 28045288 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally adapted PMTO (CA)
Number of subjects: 103
Study 28045288 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally adapted and enhanced PMTO (CE)
Number of subjects: 103
Study 28045288 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 103
Study 24842588 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based parenting skills program consisting of 10 core sessions and up to 4 supplemental sessions, including self-guided Web content and videoconference calls with a therapist.
Number of subjects: 37
Study 24842588 — intervention group
Group type: COMPARATOR
Intervention: Control group received links to TBI Web resources.
Number of subjects: 37
Study 23126609 — intervention group
Group type: EXPERIMENTAL
Intervention: Butorphanol (0.1 mg/kg bwt)
Number of subjects: 18
Study 23126609 — intervention group
Group type: EXPERIMENTAL
Intervention: Butorphanol (0.05 mg/kg bwt)
Number of subjects: 18
Study 23126609 — intervention group
Group type: COMPARATOR
Intervention: Saline (0.5 ml)
Number of subjects: 18
Study 23126609 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin temperature
Number of subjects: 18
Study 23126609 — intervention group
Group type: EXPERIMENTAL
Intervention: Behaviour score
Number of subjects: 18
Study 22256425 — intervention group
Group type: EXPERIMENTAL
Intervention: Human amniotic membrane (HAM)
Number of subjects: 18
Study 22256425 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E and selenium
Number of subjects: 18
Study 22256425 — intervention group
Group type: COMPARATOR
Intervention: Control (0.9% sodium chloride solution)
Number of subjects: 18
Study 19501213 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptive (30 mcg ethinylestradiol/150 mcg desogestrel)
Number of subjects: 36
Study 19501213 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptive (20 mcg ethinylestradiol/150 mcg desogestrel)
Number of subjects: 36
Study 19501213 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal ring contraceptive (15 mcg ethinylestradiol/120 mcg etonorgestrel)
Number of subjects: 36
Study 19501213 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptives (both high and low estrogen)
Number of subjects: 36
Study 19501213 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptives
Number of subjects: 36
Study 19501213 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal contraceptive ring
Number of subjects: 36
Study 16972231 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mmol/kg gadoversetamide
Number of subjects: 18
Study 16972231 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mmol/kg gadoversetamide
Number of subjects: 18
Study 16972231 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 mmol/kg gadoversetamide
Number of subjects: 18
Study 16972231 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed-enhancement (DE) imaging
Number of subjects: 18
Study 16972231 — intervention group
Group type: EXPERIMENTAL
Intervention: T1rho‐TFE imaging
Number of subjects: 18
Study 15567797 — intervention group
Group type: EXPERIMENTAL
Intervention: Fu needling
Number of subjects: 100
Study 15567797 — intervention group
Group type: EXPERIMENTAL
Intervention: Electric acupuncture
Number of subjects: 100
Study 15567797 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Fu needling and electric acupuncture
Number of subjects: 100
Study 11028934 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ganciclovir prophylaxis
Number of subjects: 0
Study 11028934 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 9709271 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening group (study group) invited for screening, initial examination, and three annual reexaminations using film mammography and clinical examination.
Number of subjects: 0
Study 9709271 — intervention group
Group type: COMPARATOR
Intervention: Control group (not invited for screening).
Number of subjects: 0
Study 8310723 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous amino acid mixture (10 g/h)
Number of subjects: 8
Study 8310723 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 8
Study 3521522 — intervention group
Group type: EXPERIMENTAL
Intervention: Furosemide and potassium
Number of subjects: 155
Study 3521522 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide and amiloride hydrochloride
Number of subjects: 155
Study 3521522 — intervention group
Group type: COMPARATOR
Intervention: No diuretics (control group)
Number of subjects: 155
Study 29869443 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombus aspiration (TA)
Number of subjects: 60
Study 29869443 — intervention group
Group type: COMPARATOR
Intervention: Control group (no thrombus aspiration)
Number of subjects: 60
Study 28315480 — intervention group
Group type: EXPERIMENTAL
Intervention: One-way SMS
Number of subjects: 825
Study 28315480 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-way SMS
Number of subjects: 825
Study 28315480 — intervention group
Group type: COMPARATOR
Intervention: Control (no SMS)
Number of subjects: 825
Study 26240487 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (LI) group, n = 137, 12-week multi-component intervention including individual counseling, group sessions, and self-help materials
Number of subjects: 243
Study 26240487 — intervention group
Group type: COMPARATOR
Intervention: Basic usual intervention (BI) group, n = 106, provided with one-page health information sheet on MetS and MetS management at baseline
Number of subjects: 243
Study 23563111 — intervention group
Group type: EXPERIMENTAL
Intervention: DT56a
Number of subjects: 89
Study 23563111 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone Therapy (HT)
Number of subjects: 89
Study 23563111 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 89
Study 21036378 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-washed group
Number of subjects: 424
Study 21036378 — intervention group
Group type: COMPARATOR
Intervention: Unwashed group
Number of subjects: 424
Study 18502912 — intervention group
Group type: EXPERIMENTAL
Intervention: Early surgery
Number of subjects: 283
Study 16781239 — intervention group
Group type: EXPERIMENTAL
Intervention: Stenting
Number of subjects: 1683
Study 16781239 — intervention group
Group type: COMPARATOR
Intervention: Balloon Angioplasty
Number of subjects: 1683
Study 14714769 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 100 mg/kg intravenously for one hour before CPB and 40 mg/kg/day at 24 hours after CPB
Number of subjects: 20
Study 14714769 — intervention group
Group type: COMPARATOR
Intervention: Physiologic salt solution (placebo) as a continuous intravenous infusion for one hour before CPB and 24 hours after CPB
Number of subjects: 20
Study 11099394 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated linoleic acid (CLA) 4.2 g/day for 1 month
Number of subjects: 100
Study 11099394 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 100
Study 8283363 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized albuterol
Number of subjects: 128
Study 8283363 — intervention group
Group type: COMPARATOR
Intervention: Orally administered placebo
Number of subjects: 128
Study 8283363 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized albuterol (in recurrent wheezing group)
Number of subjects: 128
Study 8283363 — intervention group
Group type: COMPARATOR
Intervention: Orally administered albuterol
Number of subjects: 128
Study 8283363 — intervention group
Group type: COMPARATOR
Intervention: Nebulized saline solution
Number of subjects: 128
Study 3051529 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg ticlopidine twice daily for up to 3 years
Number of subjects: 1072
Study 3051529 — intervention group
Group type: COMPARATOR
Intervention: Identical-appearing placebo tablets twice daily for up to 3 years
Number of subjects: 1072
Study 30922373 — intervention group
Group type: EXPERIMENTAL
Intervention: ABP 501 (40 mg every other week for 68 weeks)
Number of subjects: 466
Study 28939484 — intervention group
Group type: EXPERIMENTAL
Intervention: All-ceramic, zirconia-based posterior single crowns (SCs)
Number of subjects: 60
Study 28939484 — intervention group
Group type: COMPARATOR
Intervention: Pre-treatment patient surveys
Number of subjects: 60
Study 25010744 — intervention group
Group type: EXPERIMENTAL
Intervention: Alerts based on end‐tidal anaesthetic concentration
Number of subjects: 0
Study 25010744 — intervention group
Group type: EXPERIMENTAL
Intervention: Alerts based on bispectral index values
Number of subjects: 0
Study 23416033 — intervention group
Group type: EXPERIMENTAL
Intervention: Inflammatory challenge
Number of subjects: 0
Study 23416033 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuroimaging (18FDG-PET)
Number of subjects: 0
Study 23416033 — intervention group
Group type: EXPERIMENTAL
Intervention: Activity changes in brain regions
Number of subjects: 0
Study 20855171 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral methadone, injectable diacetylmorphine, or injectable hydromorphone (double blind) over 12 months
Number of subjects: 112
Study 20855171 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 112
Study 19523621 — intervention group
Group type: EXPERIMENTAL
Intervention: CO(2) insufflation
Number of subjects: 100
Study 19523621 — intervention group
Group type: COMPARATOR
Intervention: Air insufflation
Number of subjects: 100
Study 17497591 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein hydrolysate supplementation
Number of subjects: 18
Study 17497591 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 15386790 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 contact 20 week cognitive behavioral intervention
Number of subjects: 0
Study 11441422 — intervention group
Group type: EXPERIMENTAL
Intervention: Ecopipam (100 mg p.o.)
Number of subjects: 10
Study 11441422 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 9743296 — intervention group
Group type: EXPERIMENTAL
Intervention: Reinduction therapy with the same cytostatic treatment (5-FU/LV or 5-FU/LLV) administered at 100 mg m(‐2) day(‐1) by i.v. bolus injection, followed by 5-FU 400 mg m(‐2) day(‐1) given as a 2-h infusion for 5 consecutive days at 4-week intervals x 6 or until tumor progression.
Number of subjects: 71
Study 9743296 — intervention group
Group type: COMPARATOR
Intervention: Initial treatment with 5-FU/LV or 5-FU/LLV.
Number of subjects: 71
Study 8562297 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine (10 mg 70 kg‐1)
Number of subjects: 10
Study 8562297 — intervention group
Group type: COMPARATOR
Intervention: Morphine 6‐glucuronide (1 mg 70 kg‐1)
Number of subjects: 10
Study 8562297 — intervention group
Group type: COMPARATOR
Intervention: Morphine 6‐glucuronide (3.3 mg 70 kg‐1)
Number of subjects: 10
Study 8562297 — intervention group
Group type: COMPARATOR
Intervention: Morphine 6‐glucuronide (5 mg 70 kg‐1)
Number of subjects: 10
Study 2252243 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate (10 mg weekly for at least 6 months)
Number of subjects: 24
Study 2252243 — intervention group
Group type: COMPARATOR
Intervention: Prednisone (10 mg weekly for at least 6 months)
Number of subjects: 24
Study 7351270 — intervention group
Group type: EXPERIMENTAL
Intervention: econazole nitrate 1%
Number of subjects: 100
Study 7351270 — intervention group
Group type: EXPERIMENTAL
Intervention: econazole nitrate 1% combined with triamcinolone acetonide 0.1%
Number of subjects: 100
Study 30839302 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric training (PT)
Number of subjects: 23
Study 30839302 — intervention group
Group type: COMPARATOR
Intervention: Control group (CTRL)
Number of subjects: 23
Study 28100506 — intervention group
Group type: EXPERIMENTAL
Intervention: Twitter intervention
Number of subjects: 0
Study 25865660 — intervention group
Group type: COMPARATOR
Intervention: Standard portion size of spaghetti bolognese
Number of subjects: 0
Study 25865660 — intervention group
Group type: EXPERIMENTAL
Intervention: Larger portion size of spaghetti bolognese
Number of subjects: 0
Study 25865660 — intervention group
Group type: COMPARATOR
Intervention: Standard portion size of curry and rice
Number of subjects: 0
Study 25865660 — intervention group
Group type: EXPERIMENTAL
Intervention: Larger portion size of curry and rice
Number of subjects: 0
Study 25865660 — intervention group
Group type: COMPARATOR
Intervention: Standard portion size of ice cream
Number of subjects: 0
Study 25865660 — intervention group
Group type: EXPERIMENTAL
Intervention: Larger portion size of ice cream
Number of subjects: 0
Study 25865660 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-meal intentions
Number of subjects: 0
Study 23591549 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral ultrasound-guided subcostal TAP block injections after induction of general anesthesia
Number of subjects: 70
Study 23591549 — intervention group
Group type: COMPARATOR
Intervention: None (Control group)
Number of subjects: 70
Study 21112641 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal intervention (nine‐unit self‐guided workbook with weekly telephone support)
Number of subjects: 143
Study 21112641 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 143
Study 19232016 — intervention group
Group type: EXPERIMENTAL
Intervention: Latanoprost
Number of subjects: 2149
Study 19232016 — intervention group
Group type: COMPARATOR
Intervention: Dorzolamide combined with timolol
Number of subjects: 2149
Study 17380232 — intervention group
Group type: EXPERIMENTAL
Intervention: RIX4414 live attenuated human rotavirus vaccine (10^5.8 FFU)
Number of subjects: 194
Study 17380232 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 194
Study 14997172 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuation treatment with mirtazapine
Number of subjects: 410
Study 14997172 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 410
Study 11711508 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine (2.5, 5, or 10 mg once daily)
Number of subjects: 171
Study 11711508 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 171
Study 9025120 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 27
Study 9025120 — intervention group
Group type: COMPARATOR
Intervention: Comparison subjects
Number of subjects: 27
Study 9025120 — intervention group
Group type: COMPARATOR
Intervention: Biological parents of ADHD boys
Number of subjects: 27
Study 9025120 — intervention group
Group type: COMPARATOR
Intervention: Adoptive parents of ADHD boys
Number of subjects: 27